5441722025-03-205441722025-03-202025-03-20iso4217:INRxbrli:pureINDEGENE LIMITEDINDGNNewAcquisition (including agreement to acquire)2025-03-19The Company has made additional investment in its wholly owned subsidiary. The figures in euros have been converted into INR taking the Exchange Rate2025-03-20Indegene LimitedSubsidiaryIndegene Ireland Limited56100000-832000001620100000true2025-03-192025-03-18falsefalsetrue2025-03-19HealthcareThis investment in Indegene Ireland Limited is to support the Subsidiary with capex requirement intended to expand its business, the details of which shall be communicated to the Exchanges in due course.NotrueOn or before April 30, 2026Cash2906000001Indegene Ireland Limited was incorporated as a private Company, limited by shares under the Companies Act 2014 and received its certificate for commencement of business on 14th June 2019. The address of its registered office is Block A, Heritage Business Park, Mahon Industrial Estate, Blackrock, Cork, Ireland. Indegene Ireland Limited is engaged in providing of solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and healthcare organizations as authorized by its constitutional documents. Indegene Ireland Limited was a subsidiary of ILSL Holdings, Inc. (a wholly owned subsidiary of the Indegene Limited) till 30 June 2023, post which, it was 100% acquired by Indegene Limited, by entering into a definitive agreement. The turnover of Indegene Ireland Limited for last 3 years is given below: March-2022: €322,452 March-2023: €477,388 March-2024: €596,780IrelandThe related party transaction does not require any shareholder approval hence Board Meeting date has been mentioned for validation purpose.